Dermatitis, atopic Trials in Fountain Valley, United States
Conditions / Dermatitis, atopic / Fountain Valley, United States
Dermatitis, atopic is a medical condition with active clinical research programs worldwide.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03627767 | Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects | COMPLETED | PHASE3 |
| NCT06130566 | A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis | COMPLETED | PHASE3 |
| NCT06015308 | A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo | COMPLETED | PHASE2 |
| NCT06881251 | A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT04800315 | A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE2 |
| NCT06407934 | A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03428646 | Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) | ACTIVE_NOT_RECRUITING | — |
| NCT05999799 | A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis | TERMINATED | PHASE2 |
| NCT05492578 | Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials | ENROLLING_BY_INVITATION | PHASE2/PHASE3 |
| NCT03422822 | Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis | COMPLETED | PHASE3 |